Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: A systematic review

Journal of Gastrointestinal Surgery

Volumn 7, Issue 5, 2003, Pages 606-626

  Turnage, Richard H ^a   Sarosi, George ^b   Cryer, Byron ^b   Spechler, Stuart ^b   Peterson, Walter ^b   Feldman, Mark ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antrectomy; Parietal cell vagotomy; Peptic ulcer disease; Recurrent peptic ulcer disease; Vagotomy

Indexed keywords

ANTIBIOTIC AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; EVALUATION; HELICOBACTER PYLORI; HUMAN; MEDLINE; MORBIDITY; PEPTIC ULCER; POSTOPERATIVE PERIOD; RECURRENT DISEASE; REVIEW; RISK; VAGOTOMY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; VAGOTOMY;

EID: 0037704511     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(02)00034-3     Document Type: Review

References (85)

1. Antes G., Galandi D., Bouillon B. What is evidence-based medicine. Langenbecks Arch Surg. 384:1999;409-416.
2. AHCPR (1992) Acute pain management: Operative or medical procedures and trauma. Clinical practice guideline No. 1. AHCPR Publication No. 92-003.
3. Meisner S., Jorgensen L.N., Jensen H.E. The Kaplan and Meier and the Nelson estimate for the probability of ulcer recurrence 10 and 15 years after parietal cell vagotomy. Ann Surg. 207:1988;1-3.
4. Johnston G.W., Spencer E.F.A., Wilkinson A.J., Kennedy T.L. Proximal gastric vagotomy. Follow-up at 10-20 years Br J Surg. 78:1991;20-23.
5. von Holstein C., Graffner H., Oscarson J. One hundred patients ten years after parietal cell vagotomy. Br J Surg. 74:1987;101-103.
6. Koruth N.M., Dua K.S., Brunt P.W., Matheson N.A. Comparison of highly selective vagotomy with truncal vagotomy and pyloroplasty. Results at 8-15 years Br J Surg. 77:1990;70-72.
7. Jordan P.H. Jr., Thornby J. Twenty years after parietal cell vagotomy or selective vagotomy antrectomy for treatment of duodenal ulcer. Final report Ann Surg. 220:1994;283-296.
8. Hoffman J., Olesen A., Jensen H.E. Prospective 14- to 18-year follow-up study after parietal cell vagotomy. Br J Surg. 74:1987;1056-1059.
9. Hoffman J., Jensen H.-E., Christiansen J., Olesen A., Loud F.B., Hauch O. Prospective controlled vagotomy trial for duodenal ulcer. Results after 11-15 years Ann Surg. 209:1989;40-45.
10. Macintyre I.M.C., Millar A., Smith A.N., Small W.P. Highly selective vagotomy 5-15 years on. Br J Surg. 77:1990;65-69.
11. Herrington J.L., Davidson J., Shumway S.J. Proximal gastric vagotomy. Follow-up of 109 patients for 6-13 years Ann Surg. 204:1986;108-113.
12. Koo J., Lam S.K., Chan P., Lee N.W., Lam P., Wong J., Ong G.B. Proximal gastric vagotomy, truncal vagotomy with drainage, and truncal vagotomy with antrectomy for chronic duodenal ulcer. A prospective, randomized controlled trial Ann Surg. 197:1983;263-271.
13. Taylor T.V., Lythgoe J.P., McFarland J.B., Gilmore I.T., Thomas P.E., Ferguson G.H. Anterior lesser curve seromyotomy and posterior truncal vagotomy versus truncal vagotomy and pyloroplasty in the treatment of chronic duodenal ulcer. Br J Surg. 77:1990;1007-1009.
14. Schirmer B.D., Meyers W.C., Hanks J.B., Kortz W.J., Jones R.S., Postlethwait R.W. Marginal ulcer. A difficult problem Ann Surg. 195:1982;653-661.
15. Bambach C.P., Coupland G.A.E., Cumberland V.H., Lorang M.E. Surgery for recurrent peptic ulceration. Aust NZ J Surg. 48:1978;141-147.
16. Jensen H.E., Kjaergaard J., Meisner S. Ulcer recurrence two to twelve years after parietal cell vagotomy for duodenal ulcer. Surgery. 94:1983;802-806.
17. Andersen D., Hostrup H., Amdrup E. The Aarhus county vagotomy trial. II. An interim report on reduction in acid secretion and ulcer recurrence rate following parietal cell vagotomy and selective gastric vagotomy. World J Surg. 2:1978;91-100.
18. Johnston D., Blackett R.L. Recurrent peptic ulcers. World J Surg. 11:1987;274-282.
19. Kinney E., Goderwis D., Mullins R.J., Larson G.M. Management of recurrent duodenal ulcer disease. Am Surg. 54:1988;15-18.
20. Lee Y.T., Sung J.J.Y., Choi C.L., Chan F.K.L., Ng E.K.W., Ching J.Y.L., Leung W.K., Chung S.C.S. Ulcer recurrence after gastric surgery. Is Helicobacter pylori the culprit? Am J Gastroenterol. 93:1998;928-931.
21. Hirschowitz B.I., Lanas A. Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. Gastroenterology. 114:1998;883-892.
22. Heppell J., Bess M.A., McIlrath D.C., Dozois R.R. Surgical treatment of recurrent peptic ulcer disease. Ann Surg. 198:1983;1-4.
23. Thirlby R.C. Postoperative recurrent ulcer. Gastroenterol Clin North Am. 23:1994;295-311.
24. McFadden D.W., Zinner M.J. Reoperation for recurrent peptic ulcer disease. Surg Clin North Am. 71:1991;77-92.
25. Mosiman F., Donovan I.A., Alexander-Williams J. Pitfalls in the diagnosis of recurrent ulceration after surgery for peptic ulcer disease. J Clin Gastroenterol. 7:1985;133-136.
26. Perrault J., Fleming C.R., Dozois R.R. Surreptitious use of salicylates. A cause of chronic recurrent gastroduodenal ulcers Mayo Clin Proc. 63:1988;337-342.
27. Cohen F., Valleur P., Serra J., Brisset D., Chiche L., Hautefeuille P. Relationship between gastric acid secretion and the rate of recurrent ulcer after parietal cell vagotomy. Ann Surg. 217:1993;253-259.
28. Stenquist B., Forssell H., Olbe L., Lundell L. Role of acid secretory response to sham feeding in predicting recurrent ulceration after proximal gastric vagotomy. Br J Surg. 81:1994;1002-1006.
29. Braghetto I., Csendes A., Lazo M., Rebolledo P., Diaz A., Bardavid A., Bahamonde A., Thomet G. A prospective, randomized study comparing highly selective vagotomy and extended highly selective vagotomy in patients with duodenal ulcer. Am J Surg. 155:1988;443-446.
30. Feldman M., Richardson C.T., Fordtran J.S. Experience with sham feeding as a test for vagotomy. Gastroenterology. 79:1980;796-800.
31. Emas S., Grupcev G., Ericksson B. Ten-year follow-up of a prospective, randomized trial of selective proximal vagotomy with ulcer excision and partial gastrectomy with gastroduodenostomy for treating corporeal gastric ulcer. Am J Surg. 167:1994;596-600.
32. Stoddard C.J., Johnson A.G., Duthie H.L. The four to eight year results of the Sheffield trial of elective duodenal ulcer surgery - Highly selective or truncal vagotomy. Br J Surg. 71:1984;779-782.
33. Kjaergaard J., Jensen H.-E., Allermand H. Inadequately reduced acid secretion after vagotomy for duodenal ulcer. A follow-up study three to nine years after surgery Ann Surg. 192:1980;711-715.
34. Lanas A., Sekar C., Hirschowitz B.I. Objective evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding. Gastroenterology. 103:1992;862-869.
35. Lanas A., Serrano P., Bajador E., Esteva F., Benito R., Sainz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology. 112:1997;683-689.
36. Weaver G.A., Harper R.L., Storey J.A., Jenkins P.L., Merrell N.B. Nonsteroidal anti-inflammatory drugs are associated with gastric outlet obstruction. J Clin Gastroenterol. 20:1997;196-198.
37. Van der Hulst R., Rauws E.A.J., Koycu B., Keller J.J., Bruno M.J., Tijssen J.G.P., Tytgat G.N.J. Prevention of ulcer recurrence after eradication of Helicobacter pylori. A prospective long-term follow-up study Gastroenterology. 113:1997;1082-1086.
38. Hawkey C.J., Karrasch J.A., Szczepanski L., Walker D.G., Barkun A., Swannell A.J., Yeomans N.D. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. the OMNIUM study N Engl J Med. 338:1998;727-734.
39. Hawkey C.J. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Am J Med. 104:1998;67S-74S.
40. Cryer B., Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology. 117:1999;17-25.
41. The SALT Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991;338:1345-1349.
42. Allison M.C., Howatson A.G., Torrance C.J., Lee F.D., Russell R.I. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 327:1992;749-754.
43. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-69.
44. Hentschell E., Brandstatter G., Dragosics B., Hirschl A.M., Nemec H., Schutze K., Taufer M., Wurzer H. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 328:1993;308-312.
45. Graham D.Y., Lew G.M., Klein P.D., Evans D.G., Evans D.J., Saeed Z.A., Malaty H.M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study Ann Intern Med. 116:1992;705-708.
46. Peetsalu A., Maaroos H.I., Sipponen P., Peetsalu M. Long-term effect of vagotomy on gastric mucosa and Helicobacter pylori in duodenal ulcer patients. Scand J Gastroenterol. 26(Suppl 186):1991;77-83.
47. Leivonen M.K., Haglund C.H., Nordling S.F. Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease. Eur J Gastroenterol Hepatol. 9:1997;371-374.
48. Peetsalu M., Maaroos H.I., Peetsalu A. Completeness of vagotomy, Helicobacter pylori colonization and recurrent ulcer 9 and 14 years after operation in duodenal ulcer patients. Eur J Gastroenterol Hepatol. 10:1998;305-311.
49. Leivonen M.K., Nordling S.F., Haglund C.H. The course of Helicobacter pylori infection after partial gastrectomy for peptic ulcer disease. Hepatogastroenterology. 45:1998;587-591.
50. Schilling D., Adamek H.E., Wilke J., Schauwecker P., Martin W.R., Arnold J.C., Benz C., Labenz J., Riemann J.E. Prevalence and clinical importance of Helicobacter pylori infection in patients after partial gastric resection for peptic ulcer disease. A prospective evaluation of Helicobacter infection on 50 resected patients compared with matched nonresected controls. Z Gastroenterol. 37:1999;127-132.
51. Csendes A., Smok G., Coronel M., Avendano R., Zenteno G., Cordova H. The presence of Helicobacter pylori in nonoperated duodenal ulcer patients compared to patients late after highly selective vagotomy. Dig Dis Sci. 41:1996;2366-2368.
52. Sito E., Konturek P.C., Konturek S.J., Bielanski W., Stachura J. Helicobacter pylori infection after gastrectomy and vagotomy in duodenal ulcer patients. J Physiol Pharmacol. 47:1996;229-237.
53. Reeder D.D., Jackson B.M., Ban J., Clendinnen B.G., Davidson W.D., Thompson J.C. Influence of hypercalcemia on gastric secretion and serum gastrin concentrations in man. Ann Surg. 172:1970;540-546.
54. Wilson S.D., Singh R.B., Kalkhoff R.K. Does hyperparathyroidism cause hypergastrinemia? Surgery. 80:1976;231-237.
55. Linos D.A., van Heerden J.A., Abboud C.F., Edis A.J. Primary hyperparathyroidism and peptic ulcer disease. Arch Surg. 113:1978;384-386.
56. Hangen D., Maltz G.S., Anderson J.E., Knauer C.M. Marked hypergastrinemia in gastric outlet obstruction. J Clin Gastroenterol. 11:1989;442-444.
57. Amdrup E., Brandsborg M., Brandsborg O., Lovgreen N.A. Interrelationship between serum gastrin concentration, gastric acid secretion, and gastric emptying rate in recurrent peptic ulcer. World J Surg. 3:1979;235-240.
58. Stabile B.E., Passaro E. Jr. Recurrent peptic ulcer. Gastroenterology. 70:1976;124-135.
59. Kirulik L.B., Merendino K.A. An experimental study of the buffering capacity of the contents of the upper small bowel. Surgery. 35:1954;532-537.
60. Kirulik L.B., Merendino K.A. An elucidation of the intestinal sensitivity factor and the distance factors in the incidence of stomal ulcer in the Bilroth II type of gastroenterostomy. Surgery. 35:1954;538-546.
61. Nuboer J.F. Recurrent ulceration after surgical treatment of gastroduodenal peptic ulcer. Ann R Coll Surg Engl. 28:1961;303-320.
62. Lewin J.L., Yang K., Ulrich T., Elashoff J.D., Walsh J. Primary gastrin cell hyperplasia. Report of five cases and a review of the literature Am J Surg Pathol. 8:1987;821-832.
63. Friesen S.R., Tomita T. Further experience with pseudo-Zollinger-Ellison syndrome. Its place in the management of neuroendocrine duodenal ulceration World J Surg. 8:1984;552-560.
64. Graham D.Y., Opekun A., Lew G.M., Evans D.J. Jr., Klein P.D., Evans D.G. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol. 85:1990;394-398.
65. Levi S., Beardshall K., Swift I., Foulkes W., Playford R., Ghosh P., Calam J. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers. Effect of eradicating the organism BMJ. 299:1989;1504-1505.
66. Wolfe M.M., Jain D.K., Edgerton J.R. Zollinger-Ellison syndrome associated with persistently normal fasting serum gastrin concentrations. Ann Intern Med. 103:1985;215-217.
67. Weber H.C., Orbuch M., Jensen R.T. Diagnosis and management of Zollinger-Ellison syndrome. Semin Gastrointest Dis. 6:1995;79-89.
68. Gugler R., Lindstaedt H., Miederer S., Mockel W., Rohner H.G., Schmitz H., Szekessy T. Cimetidine for anastomotic ulcers after partial gastrectomy. A randomized controlled trial N Engl J Med. 301:1979;1077-1080.
69. Stage J.G., Friis J., Nielsen O.V. Ranitidine treatment of patients with postoperative recurrent ulcers. Scand J Gastroenterol. 86(Suppl):1983;80. [abstr].
70. Koo J., Lam S.K., Ong G.B. Cimetidine versus surgery for recurrent ulcer after gastric surgery. Ann Surg. 195:1982;406-412.
71. Binder H.J., Cocco A., Crossley R.J., Finkelstein W., Font R., Friedman G., Groarke J., Hughes W., Johnson A.F., McGuigan J.E., Summers R., Vlahcevic R., Wilson E.C., Winship D.H. Cimetidine in the treatment of duodenal ulcer. A multicenter double blind study Gastroenterology. 74:1978;380-388.
72. Legerton C.W. Duodenal and gastric ulcer healing rates. a review Am J Med. 77(Suppl 5B):1984;2-7.
73. Gitlin N., McCullough A.J., Smith J.L., Mantell G., Berman R. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gastroenterology. 92:1987;48-53.
74. Dekkers C.P.M., Beker J.A., Thjodleifsson B., Gabryelewicz A., Bell N.E., Humphries T.J.et al. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer. A European multicentre study Aliment Pharmacol Thera. 13:1999;179-186.
75. Poynard T., Lemaire M., Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcers. Eur J Gastroenterol Hepatol. 7:1995;661-665.
76. Yeomans N.D., Tulassay Z., Juhasz L., Racz I., Howard J.M., van Rensburg C.J., Swannell A.J., Hawkey C.J. A comparison of omeprazole with randitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. The ASTRONAUT study group N Engl J Med. 338:1998;719-726.
77. Gabriel S.E., Jaakkimainen L., Bombardier C. Risks for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 115:1991;787-796.
78. Browder W., Thompson J., Youngberg G., Walters D. Delayed ulcer recurrence after gastric resection. A new post-gastrectomy syndrome Am Surg. 63:1997;1091-1096.
79. Feldman M., Richardson C.T., Fordtran J.S. Effects of sham feeding on gastric acid secretion in healthy subjects and duodenal ulcer patients. Evidence for increased basal vagal tone in some ulcer patients Gastroenterology. 79:1980;796-800.
80. Ingvar C., Adami H.O., Enander L.K., Enskog L., Rydberg B. Clinical results of reoperation after failed highly selective vagotomy. Am J Surg. 152:1986;308-312.
81. Hoffman J., Meisner S., Jensen H.E. Antrectomy for recurrent ulcer after parietal cell vagotomy. Br J Surg. 70:1983;120-121.
82. Thirlby R.C., Feldman M. Transthoracid vagotomy for postoperative peptic ulcer. Effects on basal, sham feeding- and pentagastrin-stimulated acid secretion and on clinical outcome Ann Surg. 201:1985;648-655.
83. Laws H.L., Naughton M.J., McKernan J.B. Thoracoscopic vagectomy for recurrent peptic ulcer disease. Surgical Laparosc Endosc. 2:1992;24-28.
84. Hoffman J., Shokouh-Amiri M.H., Klarskov P., Madsen O.G., Jensen H.E. Gastrectomy for recurrent ulcer after vagotomy. Five- to nineteen-year follow-up Surgery. 99:1986;517-522. 77.
85. Toftgaard C. Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation. Ann Surg. 210:1989;159-164.